{"id":1403,"date":"2016-11-10T13:46:19","date_gmt":"2016-11-10T12:46:19","guid":{"rendered":"http:\/\/semmelweis.hu\/symposium\/?page_id=1403"},"modified":"2018-01-17T13:52:02","modified_gmt":"2018-01-17T12:52:02","slug":"posters","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/symposium\/en\/archive\/semmelweis-symposium-2016\/posters\/","title":{"rendered":"Posters 2016"},"content":{"rendered":"\n\n\n
\n

\u00a0<\/p>\n

P1: The role of CD49d expression in chronic lymphocytic leukemia cells
\n <\/strong>Csilla Tolnai-Kriston, M\u00e1rk Plander, \u00c1gnes M\u00e1rk, Anna sebesty\u00e9n, Andr\u00e1s Matolcsy, G\u00e1bor Barna
\n 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest\u00a0<\/em><\/p>\n

\u00a0<\/p>\n

P2: Effect of lenalidomide on viability and surface molecule expression of chronic lymphocytic leukemia (CLL) cells
\n <\/strong>Csilla Tolnai-Kriston, M\u00e1rk Hern\u00e1df\u0151i, Ferenc Tak\u00e1cs, Andr\u00e1s Matolcsy, G\u00e1bor Barna
\n 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest\u00a0
\n <\/strong><\/em><\/p>\n

\u00a0<\/p>\n

P3:\u00a0<\/strong>Convergence of somatic mutations within<\/strong> the JAK-STAT signalling pathway in a novel<\/strong> RUNX1<\/em><\/strong>-mutated pedigree
\n <\/strong>Kiran Tawana (1), Jun Wang (1), P\u00e9ter Kir\u00e1ly (2,3), D\u00f3ra Marosv\u00e1ri (2,3), Kriszti\u00e1n K\u00e1llay (4), G\u00e1bor Beny\u00f3 (4), Ahad el Seraihi (1), Gergely Kriv\u00e1n (4), Marianna Zombori (5), Attila Tordai (6), Judit Csomor (2), Jude Fitzgibbon (1), Csaba B\u00f6d\u00f6r (2,3)
\n (1) <\/em>Barts Cancer Institute, Centre for Haemato-Oncology, London, UK<\/em>; (2)<\/em> Semmelweis University, Department of Pathology and Experimental Cancer Research, Budapest, Hungary<\/em>;<\/em> (3)\u00a0<\/em>MTA-SE Lendulet Molecular Oncohematology Research Group; (4) <\/em>Szt. L\u00e1szl\u00f3 Hospital, Budapest, Hungary<\/em>\u00a0(5) Heim Pal Children Hospital, Budapest, Hungary; (6) National Blood Transfusion Institute, Budapest, Hungary<\/em><\/p>\n

 <\/p>\n

P4:\u00a0The effect of microenvironmental factors on the development of myeloma cells<\/strong>
\n G\u00e1bor Barna (1), \u00c1gnes M\u00e1rk (1), Gergely Varga (2), Botond Tim\u00e1r (1), Csilla Kriston (1), Orsolya Szab\u00f3 (1), Linda De\u00e1k (1), Andr\u00e1s Matolcsy (1)
\n (1) 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary (2) 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hunga<\/em>ry<\/p>\n

\u00a0<\/p>\n

P5:\u00a0mTOR activity is reduced in PCNSL
\n <\/strong>D\u00f3ra Marosv\u00e1ri (1, 2), No\u00e9mi Nagy (1), Csilla Kriston (1), Be\u00e1ta De\u00e1k (3), Zolt\u00e1n Sz\u00e1ll\u00e1si (4, 5, 6)\u00a0 Anna Sebesty\u00e9n (1, 7), Lilla Reiniger (1, 6)
\n (1): 1st Department of Pathology and Experimental Research, Semmelweis University, Budapest, Hungary;(2): MTA-SE Lendulet Molecular Oncohematology Research Group; (3): National Istitute of Oncology, Budapest, Hungary; (4): Children\u2019s Hospital Informatics Program at the Harvard\u2013Massachusetts Institute of Technology Division of Health Sciences and Technology, Harvard Medical School, Boston, MA, United States;(5): Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark; (6): 2nd Department of Pathology, MTA-SE NAP,\u00a0 Brain Metastasis Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary; (7): Tumour Progression Research Group of Joint Research Organization of Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary<\/em><\/p>\n


\n <\/strong><\/p>\n

\u00a0P6: The effects of mTORC1 inhibitor on IDH mutant cell line as a model system
\n <\/strong>Hujber Z, Pet\u0151v\u00e1ri G, Nagy N, Dank\u00f3 T, Krencz I, Szoboszlai N, Kir\u00e1ly PA, Borb\u00e9ly A, Jeney A, Sebesty\u00e9n A
\n Semmelweis University, 1st Department of Pathology and Experimental Cancer Research<\/em>
\n <\/strong><\/p>\n

 <\/p>\n

P7:\u00a0Targeting the PI3K-AKT-mTOR signalling pathway to inhibit the tumour growth in Hodgkin Lymphoma cell lines
\n <\/strong>No\u00e9mi Nagy, \u00c1gnes M\u00e1rk, Zolt\u00e1n Hujber, G\u00e1bor Pet\u0151v\u00e1ri, Bach Krisztina, Titanilla Dank\u00f3, Ildik\u00f3 Krencz, Anna Moln\u00e1r, Melinda Hajdu, Anna Sebesty\u00e9n
\n 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary<\/p>\n

 <\/p>\n

P8:\u00a0Pharmacogenetic analysis of toxic encephalopathy in pediatric acute lymphoblastic leukemia patients
\n <\/strong>J. C. S\u00e1gi (1), N. Kutszegi (1), B. Egyed (2), A. Falus1, G. T. Kov\u00e1cs (2), C. Szalai (1,3), D. J. Erd\u00e9lyi (2), \u00c1. F. Semsei (1)
\n (1) Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary (2) 2nd Department of Paediatrics, Semmelweis University, Budapest, Hungary (3) Heim Pal Children Hospital, Budapest, Hungary\u00a0<\/p>\n

\u00a0<\/p>\n

P9: Altered MicroRNA Expression in Folliculotropic and Transformed Mycosis Fungoides
\n <\/strong>D\u00f3ra Marosv\u00e1ri (1,2) Vanda T\u00e9gl\u00e1si (1) Ir\u00e9n Csala (3) M\u00e1rta Marschalk\u00f3 (4) Judit H\u00e1rsing (4) Csaba B\u00f6d\u00f6r (1,2) Botond Tim\u00e1r (1), Judit Csomor (1) Lilla Reiniger (1,5)
\n (1) 1st Department of Pathology and Experimental Research, Semmelweis University, Budapest, Hungary (2) MTA-SE Lendulet Molecular Oncohematology Research Group (3) Institute of Behavioural Sciences, Semmelweis University, Budapest, Hungary (4) Department of Dermatovenerology and Dermatooncology, Semmelweis University, Budapest, Hungary (5) 2nd Department of Pathology, MTA-SE NAP, Brain Metastasis Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary<\/em><\/p>\n

\u00a0<\/p>\n

P10:\u00a0Interferon-gamma production based virus specific T cell detection by functional flow cytometry test after allogeneic haematopoetic stem cell transplantation
\n <\/strong>Tasnady Sz, Karaszi E, Hardi A, Szederjesi A, Bihari Gy, Krivan G, Reti M, Masszi T
\n United St Istvan and St Laszlo Hospital, Budapest, Hungary; Semmelweis University, Budapest, Hungary<\/em><\/p>\n

 <\/p>\n

P11:\u00a0Metabolic characterization and detection of 2-hydroxyglutarate in different tumour samples
\n <\/strong>G\u00e1bor Pet\u0151v\u00e1ri (1), Zolt\u00e1n Hujber (1), Titanilla Dank\u00f3 (1), Norbert Szoboszlai (2), No\u00e9mi Nagy (1), Ildik\u00f3 Krencz (1), P\u00e9ter A. Kir\u00e1ly (1,4), Regina Raffay (1), \u00a0Andr\u00e1s Jeney (1), Anna Sebesty\u00e9n (1,3)\u00a0
\n (1) 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary (2) Laboratory of Environmental Chemistry and Bioanalytics, Department of Analytical Chemistry, Institute of Chemistry, E\u00f6tv\u00f6s Lor\u00e1nd University, Budapest, Hungary (3) Tumor Progression Research Group Joint Research Organization of Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary (4) Lend\u00fclet Molecular Oncohematology Research Group of Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary<\/em><\/p>\n

\u00a0<\/p>\n

P12:\u00a0Tumor-to-tumor metastasis: An initial manifestation of systemic disease
\n <\/strong>Hajnalka Rajnai, Lilla Reiniger
\n Semmelweis University, 1st Department of Pathology and Experimental Cancer Research
\n <\/strong><\/em><\/p>\n

 <\/p>\n

P13:\u00a0In search of the molecular background of cyclic thrombocytopenia and thrombocytosis
\n <\/strong>Hajnes J, Szab\u00f3 Diana Lili, Szili B, B\u00f6d\u00f6r Cs,Nagy Zs, Demeter J
\n 1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary<\/em>
\n <\/strong><\/p>\n

 <\/p>\n

P14: The possibility of treatment free remission in a large multicentric chronic myeloid leukemia population in Hungary
\n <\/strong>Richard Kiss et al.
\n MTA-SE Lendulet Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Budapest<\/em>
\n <\/strong><\/p>\n

\u00a0<\/p>\n

P15:\u00a0Cardiovascular aspects of chronic myeloid leukemia treated with tyrosine kinase inhibitors
\n <\/strong>J\u00falia Ga\u00e1l-Weisinger, Orsolya Mucsi, G\u00e1bor K\u00f6r\u00f6smezey, Bal\u00e1zs Szili, Ilona T\u00e1rk\u00e1nyi, Judit Csomor, Zsolt Nagy, Judit Demeter
\n 1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary<\/em>
\n <\/strong><\/p>\n

 <\/p>\n

P16:\u00a0Variant allele frequency of JAK2 V617F and CALR mutations and their clinical significance in Philadelphia negative myeloproliferative neoplasms
\n <\/strong>Ambrus Gango et al.
\n MTA-SE Lendulet Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Budapest<\/em>
\n <\/strong><\/p>\n

 <\/p>\n

P17:\u00a0Multiplex cutan B-cell lymphomas associated with \u00a0angioimmunoblastic T-cell lymphoma \u2013 case report \u00a0and review of the literature<\/strong>
\n Moln\u00e1r D\u00e1vid (1), Gy\u00f6ngy\u00f6si N\u00f3ra (2), Paksi Melinda (3), Demeter Judit (3), Kuroli Enik\u0151 (2), Marschalk\u00f3 M\u00e1rta (2), Csomor Judit (1), Matolcsy Andr\u00e1s (1), Szepesi \u00c1gota (1)<\/em>
\n (1) 1st Department of \u00a0Pathology and Experimental Cancer Research, (2)Department of Dermatology, Venerology and Dermatooncology, (3) 1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary<\/em><\/p>\n

\u00a0<\/p>\n

P18:\u00a0Actinomycosis- a diagnostic challenge 8 years after complete remission of diffuse large B cell lymphoma\u00a0
\n <\/strong>Hanna Eid (1), Ildik\u00f3 Istenes (1), Gabriella Gy\u0151ri (2), J\u00e1nos Sink\u00f3 (3) Eszter Sz\u00e9kely (4), Judit Demeter (1)
\n (1) Semmelweis University, 1st Department of Medicine (2) Semmelweis University, Department of Radiology (3) Department of Hematology and HSCT, United Szent Istv\u00e1n and Szent L\u00e1szl\u00f3 Hospital (4) Semmelweis University, 2nd Department of Pathology and Experimental Cancer Research<\/em>
\n <\/strong><\/p>\n

\u00a0<\/p>\n

P19: Treatment strategies and outcome of classical hairy cell leukemia (HCL) and HCL-variant differ due to differences in their molecular background\u00a0
\n <\/strong>S\u00e1ri E (1), K\u00f6r\u00f6smezey G (1), Kir\u00e1ly P (1,2), T\u00e1rk\u00e1nyi I (1), Hanna E (1), B\u00f6d\u00f6r Cs (2), Csomor J (2), Nagy Zs (1), Demeter J (1)
\n (1) Semmelweis University, 1st Department of Internal Medicine (2) MTA-SE Lend\u00fclet Molecular Oncohematology Research Group<\/em>
\n <\/strong><\/p>\n

\u00a0<\/p>\n

P20:\u00a0Severe cold autoimmune hemolytic anaemia associated with Waldenstr\u00f6m macroglobulinaemia: – longterm success of treatment with rituximab- CVP protocol
\n <\/strong>Ildik\u00f3 Istenes (1), Judit Jakab (2) , Judit Csomor (3), Zsolt Nagy (1), Judit Demeter (1)
\n (1) Semmelweis University, 1st. Dept of Medicine (2) Hungarian National Blood Transfusion Service (3) Semmelweis University, 1st Dept of Pathology and Experimental Cancer Research<\/em>
\n <\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"

\u00a0 P1: The role of CD49d expression in chronic lymphocytic leukemia cells Csilla Tolnai-Kriston, M\u00e1rk Plander, \u00c1gnes M\u00e1rk, Anna sebesty\u00e9n, Andr\u00e1s Matolcsy, G\u00e1bor Barna 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest\u00a0 \u00a0 P2: Effect of lenalidomide on viability and surface molecule expression of chronic lymphocytic leukemia (CLL) cells Csilla Tolnai-Kriston, M\u00e1rk …<\/p>\n","protected":false},"author":101021,"featured_media":0,"parent":1152,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-1403","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/users\/101021"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/comments?post=1403"}],"version-history":[{"count":10,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1403\/revisions"}],"predecessor-version":[{"id":1615,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1403\/revisions\/1615"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1152"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/media?parent=1403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/categories?post=1403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/tags?post=1403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}